Use of the steroid backbone in the search for a range of compounds as potential inhibitors of the enzyme 17β-hydroxysteroid dehydrogenase (17β-HSD)

被引：0
|
作者：
Soltani-Khankahdani, S. [1 ]
Dhanani, S. [2 ]
Owen, C. P. [1 ]
Ahmed, S. [1 ]
机构：
[1] Kingston Univ, Dept Pharm, Sch Chem & Pharmaceut Sci, Kingston, Surrey, England
[2] Kingston Univ, Sch Life Sci, Kingston, Surrey, England
来源：
JOURNAL OF PHARMACY AND PHARMACOLOGY | 2005年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S38 / S38
页数：1
相关论文
共 50 条
  • [21] Phytoestrogens as inhibitors of fungal 17β-hydroxysteroid dehydrogenase
    Kristan, K
    Krajnc, K
    Konc, J
    Gobec, S
    Stojan, J
    Rizner, TL
    STEROIDS, 2005, 70 (09) : 626 - 635
  • [22] Inhibitors of 17β-hydroxysteroid dehydrogenase type 1
    Brozic, P.
    Rizner, T. Lanisnik
    Gobec, S.
    CURRENT MEDICINAL CHEMISTRY, 2008, 15 (02) : 137 - 150
  • [23] Phytoestrogens as inhibitors of fungal 17β-hydroxysteroid dehydrogenase
    Kristan, K
    Krajnc, K
    Konc, J
    Gobec, S
    Stojan, J
    Rizner, TL
    STEROIDS, 2005, 70 (10) : 694 - 703
  • [24] Synthesis and Biological Evaluation of Spiro-δ-lactones as Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 2 (17β-HSD2)
    Xu, Kuiying
    Wetzel, Marie
    Hartmann, Rolf W.
    Marchais-Oberwinkler, Sandrine
    LETTERS IN DRUG DESIGN & DISCOVERY, 2011, 8 (05) : 406 - 421
  • [25] Involvement of 17β-hydroxysteroid dehydrogenase type 10 (17β-HSD10) in neurodegenerative disorders
    Yang, S. -Y.
    He, X. -Y.
    Brown, W. Ted
    JOURNAL OF NEUROCHEMISTRY, 2015, 134 : 346 - 346
  • [26] 17β-Hydroxysteroid dehydrogenase (HSD)/17-ketosteroid reductase (KSR) family;: nomenclature and main characteristics of the 17HSD/KSR enzymes
    Peltoketo, H
    Luu-The, V
    Simard, J
    Adamski, J
    JOURNAL OF MOLECULAR ENDOCRINOLOGY, 1999, 23 (01) : 1 - 11
  • [27] First Dual Inhibitors of Steroid Sulfatase (STS) and 17β-Hydroxysteroid Dehydrogenase Type 1 (17β-HSD1): Designed Multiple Ligands as Novel Potential Therapeutics for Estrogen-Dependent Diseases
    Salah, Mohamed
    Abdelsamie, Ahmed S.
    Frotscher, Martin
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (09) : 4086 - 4092
  • [28] In silico analysis of potential inhibitors for breast cancer targeting 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1) catalyses
    Islam, Md. Rezaul
    Tayyeb, Jehad Zuhair
    Paul, Hridoy Kumar
    Islam, Mirza Nafeul
    Oduselu, Gbolahan Oladipupo
    Bayil, Imren
    Abdellattif, Magda H.
    Al-Ahmary, Khairia Mohammed
    Al-Mhyawi, Saedah R.
    Zaki, Magdi E. A.
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2024, 28 (15)
  • [29] 17β-Hydroxysteroid Dehydrogenase 3 (17β-HSD3), a Regulator of 11β-Hydroxysteroid Dehydrogenase 1 (11β-HSD1) Activity in Rat Leydig Cell.
    Latif, S. A.
    Ge, R.
    Sottas, C. M.
    Shen, M.
    Morris, D. J.
    ENDOCRINE REVIEWS, 2010, 31 (03)
  • [30] Chemical synthesis of the 17-propanamide derivatives of stereoisomeric Δ14-17α- and 17β-estradiols: potential 17β-hydroxysteroid dehydrogenase inhibitors
    Iida, Takashi
    Ogawa, Shoujiro
    Tamegai, Hideyuki
    Adachi, Yuuki
    Saito, Hiroaki
    Ikegawa, Shigeo
    Konishi, Hiroaki
    Takagi, Akimitsu
    Matsuzaki, Takeshi
    CHEMISTRY AND PHYSICS OF LIPIDS, 2011, 164 (02) : 106 - 112
12345